Haberer Registered Investment Advisor’s Teva Pharmaceuticals TEVA Stock Holding History

Haberer Registered Investment Advisor’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-945	Closed	-$51K	–	368
2014 Q3	$51K	Buy	945 +50	+6%	+$2.65K	0.02%	152
2014 Q2	$47K	Buy	895 +165	+23%	+$8.43K	0.02%	164
2014 Q1	$38K	Buy	730 +380	+109%	+$17.6K	0.02%	175
2013 Q4	$14K	Sell	350 -50	-13%	-$1.97K	0.01%	240
2013 Q3	$15K	Buy	400 +250	+167%	+$9.75K	0.01%	253
2013 Q2	$6K	Buy	+150	New	+$5.84K	﹤0.01%	379

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Haberer Registered Investment Advisor's TEVA Position: Q4 2014 in Review

Haberer Registered Investment Advisor sold out of Teva Pharmaceuticals (TEVA) in Q4 2014, closing a stake of 945 shares — an estimated $51K sold.

Haberer Registered Investment Advisor first reported a position in TEVA in Q2 2013 and held it in 6 quarters. The position peaked at $51K in Q3 2014. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Haberer Registered Investment Advisor reported no remaining Teva Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Haberer Registered Investment Advisor sold 945 Teva Pharmaceuticals shares in Q4 2014, an estimated $51K.
Haberer Registered Investment Advisor first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Haberer Registered Investment Advisor's Teva Pharmaceuticals position peaked at $51K in Q3 2014.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Haberer Registered Investment Advisor's 13F filing for Q4 2014, filed 13 Jan 2015.